Canopy Growth Corp vs Tesla, Inc. — how do they compare? Canopy Growth Corp trades at $0.97 (market cap $398.46M), while Tesla, Inc. trades at $396.6 (market cap $1.49T). The key difference: Tesla, Inc. is far larger — about 3739.4× Canopy Growth Corp's market cap, and Tesla, Inc. is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | TSLA | |
|---|---|---|
Market Cap | $398.46M | $1.49T |
Sector | Health | Consumer Cyclical |
52-Week High | $1.92 | $489.88 |
52-Week Low | $0.86 | $302.63 |
Enterprise Value | $337.90M | $1.46T |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Tesla (TSLA) trades at $396.87, up 0.53% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces valuation challenges with a P/E ratio of 363.47 and declining profit margins, though recent earnings beat expectations in Q1 2026. Positive developments include regulatory approval for self-driving software in Europe and strong growth in German registrations.
Tesla's outlook balances innovation potential against execution risks. The stock offers exposure to autonomous driving leadership and energy growth, but faces intense EV competition and margin pressure. Analyst consensus price target of $409.26 suggests modest upside, though institutional sentiment remains divided with 39.5% buy ratings versus 18.5% sell recommendations.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →